277 related articles for article (PubMed ID: 35667236)
1. New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer's disease.
Wu JJ; Yang Y; Wan Y; Xia J; Xu JF; Zhang L; Liu D; Chen L; Tang F; Ao H; Peng C
Biomed Pharmacother; 2022 Aug; 152():113207. PubMed ID: 35667236
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg1, lights up the way for the potential prevention of Alzheimer's disease due to its therapeutic effects on the drug-controllable risk factors of Alzheimer's disease.
Wu JJ; Zhang L; Liu D; Xia J; Yang Y; Tang F; Chen L; Ao H; Peng C
J Ethnopharmacol; 2024 Jan; 318(Pt B):116955. PubMed ID: 37536646
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of ginsenoside Rg1 prevents cognitive impairment induced by isoflurane anesthesia in aged rats via antioxidant, anti-inflammatory and anti-apoptotic effects mediated by the PI3K/AKT/GSK-3β pathway.
Zhang Y; Zhang Z; Wang H; Cai N; Zhou S; Zhao Y; Chen X; Zheng S; Si Q; Zhang W
Mol Med Rep; 2016 Sep; 14(3):2778-84. PubMed ID: 27485139
[TBL] [Abstract][Full Text] [Related]
4. Effects of ginsenoside Rg1 on the expression of toll-like receptor 3, 4 and their signalling transduction factors in the NG108-15 murine neuroglial cell line.
Zhao BS; Liu Y; Gao XY; Zhai HQ; Guo JY; Wang XY
Molecules; 2014 Oct; 19(10):16925-36. PubMed ID: 25340298
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 improves Alzheimer's disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt/GSK-3β/β-catenin signaling pathway.
Yang Y; Wang L; Zhang C; Guo Y; Li J; Wu C; Jiao J; Zheng H
Chem Biol Drug Des; 2022 Jun; 99(6):884-896. PubMed ID: 35313087
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt.
Shi C; Zheng DD; Fang L; Wu F; Kwong WH; Xu J
Biochim Biophys Acta; 2012 Apr; 1820(4):453-60. PubMed ID: 22178929
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.
Quan Q; Li X; Feng J; Hou J; Li M; Zhang B
Mol Med Rep; 2020 Oct; 22(4):3277-3288. PubMed ID: 32945455
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg1 ameliorates the cognitive deficits in D-galactose and AlCl
Zhong SJ; Wang L; Gu RZ; Zhang WH; Lan R; Qin XY
Int J Med Sci; 2020; 17(8):1048-1055. PubMed ID: 32410834
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg1 attenuates amyloid-beta content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice.
Shi YQ; Huang TW; Chen LM; Pan XD; Zhang J; Zhu YG; Chen XC
J Alzheimers Dis; 2010; 19(3):977-89. PubMed ID: 20157253
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3β/tau signaling pathway and the Aβ formation prevention in rats.
Song XY; Hu JF; Chu SF; Zhang Z; Xu S; Yuan YH; Han N; Liu Y; Niu F; He X; Chen NH
Eur J Pharmacol; 2013 Jun; 710(1-3):29-38. PubMed ID: 23588117
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of ginsenoside Rg2 against memory impairment and neuronal death induced by Aβ25-35 in rats.
Cui J; Shan R; Cao Y; Zhou Y; Liu C; Fan Y
J Ethnopharmacol; 2021 Feb; 266():113466. PubMed ID: 33049344
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg1 ameliorates hippocampal long-term potentiation and memory in an Alzheimer's disease model.
Li F; Wu X; Li J; Niu Q
Mol Med Rep; 2016 Jun; 13(6):4904-10. PubMed ID: 27082952
[TBL] [Abstract][Full Text] [Related]
13. Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model.
Fang F; Chen X; Huang T; Lue LF; Luddy JS; Yan SS
Biochim Biophys Acta; 2012 Feb; 1822(2):286-92. PubMed ID: 22015470
[TBL] [Abstract][Full Text] [Related]
14. Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach.
Zarneshan SN; Fakhri S; Khan H
Pharmacol Res; 2022 Mar; 177():106099. PubMed ID: 35092819
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside-Rg1 attenuates sepsis-induced cardiac dysfunction by modulating mitochondrial damage via the P2X7 receptor-mediated Akt/GSK-3β signaling pathway.
Liu Z; Pan H; Zhang Y; Zheng Z; Xiao W; Hong X; Chen F; Peng X; Pei Y; Rong J; He J; Zou L; Wang J; Zhong J; Han X; Cao Y
J Biochem Mol Toxicol; 2022 Jan; 36(1):e22885. PubMed ID: 34859534
[TBL] [Abstract][Full Text] [Related]
16. Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer's disease.
Liang HY; Zhang PP; Zhang XL; Zheng YY; Huang YR; Zheng GQ; Lin Y
Aging (Albany NY); 2021 Mar; 13(5):7549-7569. PubMed ID: 33686024
[TBL] [Abstract][Full Text] [Related]
17. High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer's disease mice.
Li G; Zhang N; Geng F; Liu G; Liu B; Lei X; Li G; Chen X
Sci Rep; 2019 May; 9(1):7040. PubMed ID: 31065079
[TBL] [Abstract][Full Text] [Related]
18. Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation.
Zhao R; Zhang Z; Song Y; Wang D; Qi J; Wen S
J Ethnopharmacol; 2011 Feb; 133(3):1109-16. PubMed ID: 21129477
[TBL] [Abstract][Full Text] [Related]
19. New Therapeutic Approaches to and Mechanisms of Ginsenoside Rg1 against Neurological Diseases.
Sun Y; Yang Y; Liu S; Yang S; Chen C; Lin M; Zeng Q; Long J; Yao J; Yi F; Meng L; Ai Q; Chen N
Cells; 2022 Aug; 11(16):. PubMed ID: 36010610
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg1 protects human renal tubular epithelial cells from lipopolysaccharide-induced apoptosis and inflammation damage.
Ni XJ; Xu ZQ; Jin H; Zheng SL; Cai Y; Wang JJ
Braz J Med Biol Res; 2017 Dec; 51(2):e6611. PubMed ID: 29267498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
